we should be flying. . ., page-21

Lot more value in it than that with a good phase 3 and all the extras we have on the boil. It is a huge market that won't happen overnight but once the door is opened will give a big pharma a opportunity to literally extend their patent and no generic competition period and it is a money tree with the simplicity of the underlying drug already approved. Really depends how many deals on how many products they can string together and get the trials underway as it won't be a one trick pony. Huge leverage, pretty short lead time to market then protected for years and thus deep value not just imaginary blue sky that people just don't seem to grasp. They all seem happier to chase shadows elsewhere.

new management better get up to speed fast , create some share awareness and value while keeping a steady course for me to remain invested